Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways

Circulation Journal

Volumn 72, Issue 9, 2008, Pages 1506-1511

  Morimoto, Tatsuya ^a   Fujita, Masatoshi ^b   Kawamura, Teruhisa ^a   Sunagawa, Yoichi ^a   Takaya, Tomohide ^a,b   Wada, Hiromichi ^a   Shimatsu, Akira ^a   Kita, Toru ^b   Hasegawa, Koji ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Doxorubicin; p300; p53; Ubiquitin

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DOXORUBICIN; PROTEIN P300; PROTEIN P53; UBIQUITIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE CELL; HOMEOSTASIS; IMMUNOPRECIPITATION; NEWBORN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELLS, CULTURED; DOXORUBICIN; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION REGULATION; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 50449091387     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-1076     Document Type: Article

References (29)

1. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
2. Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 1999; 29: 380-386.
3. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, et al. Myocyte death in the failing human heart is gender dependent. Circ Res 1999; 85: 856-866.
4. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 2004; 43: 295-301.
5. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87: 953-959.
6. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem 1995; 270: 7791-7794.
7. Poizat C, Puri PL, Bai Y, Kedes L. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 2005; 7: 2673-2687.
8. Poizat C, Sartorelli V, Chun G, Kloner RA, Kedes L. Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription. Mol Cell Biol 2000; 23: 8643-8654.
9. Kosugi R, Shioi T, Watanabe-Maeda K, Yoshida Y, Takahashi K, Machida Y, et al. Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart. Circ J 2006; 70: 482-488.
10. Kawamura T, Hasegawa K, Morimoto T, Iwai-Kanai E, Miyamoto S, Kawase Y, et al. Expression of p300 protects cardiac myocytes from apoptosis in vivo. Biochem Biophys Res Commun 2004; 315: 733-738.
11. Ikegami E, Fukazawa R, Kanbe M, Watanabe M, Abe M, Watanabe M, et al. Edaravone, a potent free radical scavenger, prevents anthracycline-induced myocardial cell death. Circ J 2007; 71: 1815-1820.
12. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 1997; 99: 2635-2643.
13. Halaby MJ, Yang DQ. p53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 2007; 395: 1-7.
14. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 2003; 300: 342-344.
15. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Masutani H, Kitsis RN, et al. GATA-5 is involved in leukemia inhibitory factor-responsive transcription of the beta-myosin heavy chain gene in cardiac myocytes. J Biol Chem 1999; 274: 12811-12818.
16. Kakita T, Hasegawa K, Morimoto T, Kaburagi S, Wada H, Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem 1999; 274: 34096-34102.
17. Morimoto T, Hasegawa K, Kaburagi S, Kakita T, Wada H, Yanazume T, et al. Phosphorylation of GATA-4 is involved in α1-adrenergic agonist-responsive transcription of the Endothelin-1 gene in cardiac myocytes. J Biol Chem 2000; 275: 13721-13726.
18. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, et al. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol 2003; 23: 3593-3606.
19. Finnberg N, Silins I, Stenius U, Högberg J. Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions Carcinogenesis 2004; 25: 113-122.
20. Yang Y, Li CC, Weissman AM. Regulating the p53 system through ubiquitination. Oncogene 2004; 23: 2096-2106.
21. Toth A, Nickson P, Qin LL, Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 2006; 281: 3679-3689.
22. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006; 443: 780-786.
23. Kumamoto T, Fujimoto S, Ito T, Horinouchi H, Ueyama H, Tsuda T. Proteasome expression in the skeletal muscles of patients with muscular dystrophy. Acta Neuropathol (Berl) 2000; 100: 595-602.
24. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: Structural deterioration and compensatory mechanisms. Circulation 2003; 107: 984-991.
25. Tsukamoto O, Minamino T, Okada K, Shintani Y, Takashima S, Kato H, et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 2006; 340: 1125-1133.
26. Kumarapeli AR, Horak KM, Glasford JW, Li J, Chen Q, Liu J, et al. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J 2005; 19: 2051-2053.
27. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429: 86-92.
28. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112: 779-791.
29. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2006; 2: 212-214.